Quality of Life Measures in Patients With Retinal Degeneration

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inherited retinal degeneration (IRD) is a major cause of blindness and partial loss of vision cases in the UK and starts at an early age. The purpose of this observational study is to use the results of two questionnaires and a computerised test testing contrast sensitivity, to assess the impact of IRD on quality of life. This study will involve collecting data from patients with IRD, but also collecting data from normal controls.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Visual and Functional Assessment in Low Vision Patients

NCT01876147

Retinitis Pigmentosa Age-related Macular Degeneration Optic Nerve Pathology +1 more

COMPLETED

Causes of Visual Loss in Retinal Disease

NCT01613963

Uveitis Scleritis

UNKNOWN

Coloured-light in Retinitis Pigmentosa.

NCT06224114

Retinitis Pigmentosa

NOT_YET_RECRUITING NA

The Impact of Rehabilitation on Quality of Life in Visually Impaired

NCT00013403

Blindness

COMPLETED PHASE2

Performance of Long-wavelength Autofluorescence Imaging

NCT03592017

Retinal Disease Retinal Degeneration Retinal Dystrophies

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

IRD presents a significant burden on the NHS as well as on the individual and families. IRDs are particularly difficult in a family situation due to guilt and other complex emotions related to inheritance patterns. Poorer mental health has been reported in patients with retinitis pigmentosa, manifesting in a range of ways including stress, depression and anxiety, particularly as the disease progresses. This is most probably caused by the uncertainty of the disease process and the progressive nature of the degeneration.

Recent work has reported that quality of life significantly deteriorates with a drop in visual field diameter of 20 degrees or a drop in visual acuity lower then LogMAR 0.3 (equivalent to 6/12). Contrast sensitivity is often used in conjunction with VA to assess visual capabilities. It is a measure of the ability to see reduced contrast and has a major impact on utility of vision. Relating contrast sensitivity function to quality of life will provide valuable information about whether this aspect of vision is a critical measure for patient health. This is especially important as novel treatments are being developed for the treatment of IRDs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

Patients with inherited retinal degeneration will answer two questionnaires and undergo a computerised contrast sensitivity function test.

Questionnaire

Intervention Type OTHER

The participants will answer two questionnaires. These are the NEI VFQ-25 and the DLTV (daily living tasks of vision).

Computerised contrast sensitivity function test

Intervention Type OTHER

This test involves the patient identifying whether bars on a screen are horizontal or vertical. It is designed to measure contrast sensitivity.

Normal controls

Normal controls recruited by advertising will answer two questionnaires and undergo a computerised test that assess contrast sensitivity function.

Questionnaire

Intervention Type OTHER

The participants will answer two questionnaires. These are the NEI VFQ-25 and the DLTV (daily living tasks of vision).

Computerised contrast sensitivity function test

Intervention Type OTHER

This test involves the patient identifying whether bars on a screen are horizontal or vertical. It is designed to measure contrast sensitivity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

The participants will answer two questionnaires. These are the NEI VFQ-25 and the DLTV (daily living tasks of vision).

Intervention Type OTHER

Computerised contrast sensitivity function test

This test involves the patient identifying whether bars on a screen are horizontal or vertical. It is designed to measure contrast sensitivity.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant is willing \& able to give informed consent for participation in the study.
* Male or female, aged 18 - 85.
* A clinical or genetic diagnosis of retinal degeneration or normal age and sex-matched controls without known retinal disease.
* Able to participate in visual function testing.

Exclusion Criteria

* The participant may not enter the study if any of the following apply:

* 1\) they have a pre-existing amblyopia or squint;
* 2\) they have any other retinal problems that may confound the measures assessed.

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes